Evolving concepts in tumour lysis syndrome management - response to Ayed et al
Br J Haematol
.
2016 May;173(3):486-7.
doi: 10.1111/bjh.13616.
Epub 2015 Jul 27.
Authors
Gail L Jones
1
,
Andrew Will
2
,
Graham H Jackson
3
,
Nicholas J Webb
4
,
Simon Rule
5
Affiliations
1
Department of Haematology, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
[email protected]
.
2
Department of Haematology, Royal Manchester Children's Hospital, Manchester, UK.
3
Department of Haematology, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
4
Department of Nephrology, Royal Manchester Children's Hospital, Manchester, UK.
5
Department of Haematology, Derriford Hospital, Plymouth, Devon, UK.
PMID:
26216044
DOI:
10.1111/bjh.13616
No abstract available
Keywords:
chemotherapy; immunotherapy; malignant haematology.
Publication types
Letter
Comment
MeSH terms
Humans
Risk Factors
Tumor Lysis Syndrome*